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ABSTRACT

Although rare isolated cases of adenocarcinoma in situ of skin have been reported in the literature,
adenocarcinoma in situ of skin as a concept and as a diagnostic category has not been established in
the field of dermatopathology. In this work, four cases of papillary adenocarcinoma in situ of the skin
are presented. In addition, the notion that lesions previously reported in the medical literature under
the term of “papillary eccrine adenoma” are actually adenocarcinoma in situ is discussed.

Introduction
In general, epithelial neoplasm can be classified into three

Materials and methods
Case history

categories, namely, benign neoplasm, carcinoma in situ (non-

Case 1

invasive carcinoma) and invasive carcinoma. When the term

The patient was a 82-year-old female with a 1.2 cm painful

carcinoma used unmodified, it generally refers to invasive

mass in her right second toe. The lesion was excised and

carcinoma. However, since the introduction of the concept

diagnosed by a dermatopathologist as sweat duct carcinoma,

of carcinoma in situ by Broder in 1932 [1], there have been

involving the specimen margins. Subsequently, amputation

only occasional case reports of adenocarcinoma in situ of skin

of the right second toe was performed. Upon review of the

in the literature [2-6]. Adenocarcinoma in situ of skin as a
concept and as a diagnostic category has not been established

amputation specimen along with the prior excision specimen,
another dermatopathologist in a different institution inter-

in the field of dermatopathology [7-9]. In this essay, four

preted the lesion as papillary eccrine adenoma.

cases of papillary adenocarcinoma in situ (PACIS) of skin

Case 2

are reported. Furthermore, the notion that lesions previously

The patient was a 47-year-old female with a 1.5 cm skin nod-

reported in the medical literature under the term of papillary

ule on her right leg. The lesion was excised and was reported

eccrine adenoma are actually PACIS is discussed.

to be adenocarcinoma with negative margins.
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TABLE 1. Clinical summary of the four cases
Sex

Lesion
location

Lesion
size

82

Female

Right 2nd toe

1.2 cm

2

47

Female

Right leg

1.5 cm

3

43

Male

Right index
finger

1.4 cm

4

68

Female

Right leg

1.8 cm

Case

Age

1

The clinical summaries of the four cases are listed in
Table 1.

Results
Histopathologic and immunocytochemical features: By light
microscopy, the tumors in all our cases consisted of circumscribed but not encapsulated intradermal proliferations of
variously-sized tubules and ducts embedded in a sclerotic

Case 3
The patient was a 43-year-old male, who presented with
a 1.4 cm lesion on his right index finger. The lesion was
excised and reported as papillary eccrine carcinoma in situ.
Subsequently the patient requested a second opinion from
two dermatopathologists from two separate institutions,
who both interpreted the lesion as aggressive digital papillary
adenocarcinoma.

stroma (Figures 1 and 2). Many of them were lined by a
double layer of cells. The outer layer composed of flattened
myoepithelial cells. The inner cells were cuboidal to columnar
and formed in most lumens papillary projections. Squamous
metaplasia was also noted in one case. Cytologically, the cells
showed mild to moderate nuclear atypia. Mitotic figures and
single cell necrosis were noted. An intact myoepithelial layer
was evident on H&E-stained sections of all four cases and
this was further confirmed by immunohistochemistry for
P63, which was performed on two cases (Cases 2 and 3),

Case 4

and revealed strong positive reaction in outer layer (Figure

The patient was a 68-year-old female with 1.8 cm nodule

3A). Ki-67 staining was performed on one case (Case 3) and

in her right leg. The nodule was excised and interpreted as

was positive in at least 30% of neoplastic cells (Figure 3B).

eccrine carcinoma in situ extending to surgical margin. Re-

Various diagnoses ranging from papillary eccrine adenoma,

excision was performed and showed focal residual tumor

carcinoma in situ, and carcinoma were rendered by different

with negative surgical margin. One month earlier, the patient

pathologists or dermatopathologists (Table 2).

had right breast mastectomy with sentinel lymph node biopsy,
which showed the presence of a 3.0 cm low-grade invasive
ductal carcinoma with mucinous features in the breast. Four

Discussion

sentinel lymph nodes were negative for tumor. Two years later,

Since the introduction of the concept of carcinoma in situ in

the patient had radical right hemicolectomy for a 10.5 cm

1932 [1], although rare cases of adenocarcinoma in situ of the

moderately to poorly differentiated adenocarcinoma of the

skin have been reported [2-6], adenocarcinoma in situ of the

cecum with 5/17 positive lymph nodes and liver metastasis.

skin as a concept and as a diagnostic category has not been

Figure 1. Case 2, papillary adenocarcinoma in situ. (A) Low power view showing a circumscribed lesion located in a fibrotic dermis (H&E,
x20); (B) Medium power view showing dilated ducts with prominent papillary projections (H&E, x100); (C) High power view showing
clearly the presence of intact myoepithelial cell layer (H&E, x400). [Copyright: ©2014 Chen et al.]
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Figure 2. Case 3, papillary adenocarcinoma in situ. (A) Low power view showing a lesion in a fibrotic dermis (H&E, x40); (B) Medium
power view showing prominent papillary structure formation (H&E, x 200); (C) High power view showing the presence of necrosis and
peripheral myoepithelial cell layer (H&E, x400). [Copyright: ©2014 Chen et al.]

established [7-9]. Conceptually cases of adenocarcinoma in

malignancy (nuclear atypia, single cell necrosis and mitotic

situ of skin must exist. The four cases presented here, in our

figures) with intact myoepithelial cell layer (no evidence

opinion, are such examples. These lesions show cytological

of invasion), fulfilling the criteria for carcinoma in situ set
forth by Broder in 1932 [1]. If one employs the diagnostic
criteria of breast pathology, these lesions are morphologically
identical to the micropapillary type of ductal carcinoma in
situ in the breast [10]. Although these cases were variably
interpreted as invasive adenocarcinoma, they are obviously
not invasive adenocarcinoma because of the presence of an
intact myoepithelial cell layer. The main reason they were
interpreted as invasive adenocarcinoma is that cutaneous
adenocarcinoma in situ has not been established as a diagnostic category or entity. When pathologists encounter these
kinds of lesions, they would classify them either as adenoma
or invasive adenocarcinoma.
In 1973, Panet-Raymond and Johnson described a very
similar lesion under the term of adenocarcinoma of the eccrine
sweat gland [11]. They reported a case of a 49-year-old man
who had a slow growing tumor on his left forearm since childhood. The tumor rapidly began to grow and for this reason it
was excised. The histopathologic features were deemed by the
authors to be adenocarcinoma of the sweat gland. However,
based on what the authors described and illustrated microscopically in their article, the lesion is identical to the cases
presented here. They called it carcinoma “on the basis of nonencapsulation, areas of intracystic papillary projections, and
the presence of hyperchromatic nuclei, a moderate number of
mitoses and some atypical cells in these latter areas.”
We believe that lesions reported under the term papil-

Figure 3. Case 3, papillary adenocarcinoma in situ. Immunocytochemical stain for P63 (A, x400) and Ki67 (B, x400). P63 stain
highlights the intact layer of myoepithelial cells. At least 30% of
neoplastic cells are positive for Ki67. [Copyright: ©2014 Chen et al.]
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lary eccrine adenoma are not adenoma but PACIS. In 1977,
Rulon and Helwig described an identical lesion but named
it for the first time “papillary eccrine adenoma” [12]. They
reported on 14 cases of distinctive cutaneous glandular
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TABLE 2. Diagnoses offered by different pathology/dermatopathology consultants
Case

1st opinion

2nd opinion

3rd opinion

1

Sweat duct carcinoma (by
dermatopathologist)

Papillary eccrine adenoma
(by dermatopathologist)

Not applicable

2

Adenocarcinoma (by
pathologist)

Not applicable

Not applicable

3

Papillary eccrine carcinoma in
situ (by dermatopathologist)

Aggressive digital papillary
adenocarcnioma (by
dermatopathologist)

Aggressive digital papillary
adenocarcnioma (by
dermatopathologist)

4

Eccrine carcinoma in situ (by
dermatopathologist)

Not applicable

Not applicable

neoplasm, which they stated, “were difficult to interpret and

In all the above examples, we think the confusion was due

had been believed to occupy the gray zone separating benign

to unawareness of adenocarcinoma in situ as a concept and

and malignant neoplasms of the sweat glands. Since none

as one diagnostic category in the skin.

was found to have metastasized, this lesion is provisionally

In 2003, Denianke and Ackerman published an article

considered benign. The diagnostic term of papillary eccrine

and claimed that the so-called papillary eccrine adenoma is

adenoma is suggested.” The lesions varied in size from 0.5 to

really apocrine papillary carcinoma [33]. Although we agree

2.0 cm and could be found in any part of the skin including

with Denianke and Ackerman that the so-called papillary

fingers and toes. Histologically the lesions they described

eccrine adenoma is not adenoma, namely, a benign glandular

are very similar, if not identical, to the four cases described

neoplasm, we believe for the reasons stated above that the

here in the present study. Regarding treatment and nature of

lesion under discussion is best categorized as PACIS, not

the lesions, Rulon and Helwig stated “surgical excision with

carcinoma, which when used unmodified generally means

assurance of complete removal by histologic examination of

invasive carcinoma.

the surgical margins is considered the treatment of choice. The

Of note, our Case 3 was interpreted as aggressive digital

lesion is considered benign on the basis of available follow-up

papillary adenocarcinoma by two dermatopathologists from

information.” As one can see, Rulon and Helwig considered

two independent institutions. This is not surprising, since

the lesions benign, namely, papillary eccrine adenoma, based

to our knowledge at least two similar cases, which were

on no recurrence or metastases following complete surgical

reported as aggressive digital papillary adenocarcinoma in

excision or digital amputation. However, this does not argue

the literature, are actually adenocarcinoma in situ in our

against the notion that the lesions were actually adenocarci-

opinion. One case appeared in an article published in 2006

noma in situ, since carcinoma in situ would behave exactly

by Crowson et al [34]. The authors illustrated a case (figures

the same way, namely, no recurrence or metastases following

15 and 16 in the article) under the term digital papillary

complete surgical excision.

adenocarcinoma and commented that histopathologically

Subsequent studies using the term papillary eccrine ade-

the lesion was “cognate to that of ductal carcinoma in situ

noma have been published by different authors, but the

of the breast.” From the photomicrographs illustrated there,

majority of them are single case reports or a small series of

it appears that an intact peripheral myoepithelial cell layer

cases [13-30]. Very few authors questioned the true nature of

was present, so we believe the case is actually adenocarci-

the lesion under discussion and most simply followed Rulon

noma in situ rather than digital papillary adenocarcinoma.

and Helwig and considered their own cases as adenomas.

The other case was presented in an article in 2010 by Hsu

In 1987, Urmacher and Lieberman reported four cases

et al [35]. The authors described an 8 mm nodule on the fin-

using the term of papillary eccrine adenoma [31]. They

ger of a 28-year-old woman diagnosed as aggressive digital

did mention that three patients were seen prior to 1977

papillary adenocarcinoma. According to the authors, the

and diagnosed with sweat gland carcinoma. Because the

lesion was excised with a positive margin, and there was no

histology in all four cases was similar to what Rulon and

evidence of disease progression at the six-year follow-up. The

Helwig described as papillary eccrine adenoma in 1977, they

photomicrographs of H&E and P63 stain provided by the

reassessed the diagnosis and described them with the term

authors for their case (figures 2 and 3 in the article) showed

papillary eccrine adenoma. Aloi and Pich admitted difficulty

clearly the presence of an intact myoepithelial cell layer. This

in differentiating between papillary eccrine adenoma and

led us (M.A. and S.C.) to conclude that the lesion actually

low-grade sweat gland carcinoma [32].

represented so-called papillary eccrine adenoma (PACIS in
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our current opinion, see above) misinterpreted as aggressive
digital papillary adenocarcinoma [36].
Of interest, in a recent book published in 2012 titled
Cutaneous Adnexal Tumors by Kazakov et al., in the pages
regarding digital papillary adenocarcinoma the existence of
adenocarcinoma in situ is mentioned briefly in these words:
“In several cases, the authors have noticed that a constant
feature is the presence of a recognizable myoepithelial cell
layer around the glands and sometimes at the peripheral
of the cystic-papillary areas. Invasion into the stroma is
sometimes seen and no myoepithelial cells are present in the
invasive foci. On the contrary, the authors have encountered
a case in which the whole lesion was endowed with a peripheral myoepithelial cell layer consistent with the concept of
carcinoma in situ” [37]. In our opinion, this is probably the
first time adenocarcinoma in situ was ever mentioned in the
acral location.
Is PACIS eccrine or apocrine origin? Rulon and Helwig
thought it of eccrine origin [12], while Denianke and Ackerman of apocrine origin [33]. Other authors pointed out a
bimodal differentiation, to wit, originating from both apocrine and eccrine (apoeccrine) origin [38]. We believe that
PACIS can derive from eccrine as well as apocrine glands.
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